ATAKA

This brand name is authorized in Nigeria.

Active ingredients

The drug ATAKA contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII L4D5UA6CB4 - DICLOFENAC POTASSIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2680	Tablet	ATAKA 50 TABLETS TAB 50 mg 10 X 10	86 RNW-PP-160455 ATAKA 50 TABLETS DICLOFENAC POTASSIUM 50MG Each film coated tablet contains: Diclofena Potassium BP 50mg Excipients q.s B4-2680 Drugs Imported Products 10X10 Prescription Only Medicine (POM) 1/21/2021 YELLOW PHARMACEUTICAL COMPANY LIMITED., , EKWULOBIA STREET WOLIWO LAYOUT, ONITSHA ANAMBRA 8090970669 yellowpharmaltd@gmail.com EUROLIFE HEALTHCARE PVT. LTD.,, Unit-II, Khasra No. 242, Village Bhagwanpur, Roorkee, Dist-Haridwar, (Uttarakhand), India. , India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB05	Diclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2680